Genpact Announces Renewed Partnership with Ferring Pharmaceuticals

Core Insights - Genpact has renewed its multi-year partnership with Ferring Pharmaceuticals to support the latter's rapid business growth through advanced technologies, including AI [1][2] - The partnership aims to transform Ferring's finance, accounting, and procurement operations, enhancing efficiency and accuracy in financial transactions [2][3] - Ferring Pharmaceuticals is committed to innovation, leveraging AI to standardize processes and improve operational efficiency, ultimately supporting its mission to help families and improve lives [3] Company Overview - Genpact is a global professional services and solutions firm with over 125,000 employees across more than 30 countries, focusing on delivering value through digital operations and technology [5] - Ferring Pharmaceuticals operates in over 50 countries and markets its medicines in over 100 countries, emphasizing research-driven biopharmaceutical solutions [1][3] Partnership Details - The renewed agreement includes streamlining workflows, optimizing resource allocation, and establishing robust data analytics capabilities for real-time financial insights [2] - Genpact will collaborate with technology partners like Xelix and Blackline to automate key processes such as invoice management and procurement workflows [2] - The partnership has already seen over 40 digital transformation projects focused on AI applications [3]